IPO Guru
Listed Mainboard

GSP Crop Science IPO Review

GSP Crop Science IPO has been reviewed by 12 analysts, and the overall consensus is Apply — carrying a score of 67. Out of the 12 analysts who have covered this IPO, 6 recommend subscribing while 6 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹304-320 per share, with a minimum application size of 46 shares (minimum investment of approximately ₹14,720 at the upper band). Subscription ran from 16 Mar 2026 to 18 Mar 2026. The issue size is ₹400 crore. As of now, the grey market premium (GMP) for GSP Crop Science IPO is quoting at ₹2 (1%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Analyst verdict & score

One score out of 100, aggregated from every analyst verdict tracked for this issue. How it's calculated

Sentiment score
67/ 100
Apply 6 of 12 recommend subscribing
How analysts voted
Apply 6
May apply 1
Neutral 3
Avoid 2
Not rated 1

Higher consensus indicates broader analyst agreement.

Detailed review

What the analyst reports say, grouped by the question you're likely asking.

General review

GSP Crop Science manufactures agrochemicals. Revenue was ₹1,301.06 crore in FY25 and ₹847.61 crore for the half year to September 2025, with EBITDA improving to ₹138.86 crore in that half. Analyst views were mixed: six of the thirteen covering it said subscribe, three stayed neutral and two said avoid.

Listing gains

The notes disagree sharply on price, valuing the issue anywhere from about 9 times half-year annualised earnings to 18.4 times FY25. One calls it clearly cheaper than peers, another calls it overvalued, and a third describes it as a premium to domestic-focused peers. That spread pointed to an uncertain listing.

Short-term strategy

Half-year EBITDA of ₹138.86 crore against ₹164.03 crore for all of FY25 suggests margins had improved materially. Agrochemical earnings depend on monsoon and crop cycles, and one note explicitly flagged uncertainty in the upcoming quarters as the reason for its avoid rating.

Long-term strategy

The positive notes rest on the company's product portfolio and manufacturing base in a sector supported by structural agricultural demand. The disagreement across the coverage was less about the long-term opportunity and more about how much of it the price already reflected, which is why ratings ranged from cheap to overvalued.

How this is written: an AI-assisted summary of the 13 analyst reports listed below. It reports their views; IPO Guru does not make buy or sell recommendations.

Analyst reviews

Ordered by each analyst's track record over the past year; analysts still building one are listed last.

Latest IPO reviews

How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.

Frequently asked

Should I apply for GSP Crop Science IPO?

The analyst consensus for GSP Crop Science IPO tracked on this page is Apply, with a score of 67/100. Out of 12 analysts who have reviewed this IPO, 6 recommend subscribing. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.

What does the score of 67 mean for GSP Crop Science IPO?

The score of 67 is an aggregate of all analyst ratings tracked for GSP Crop Science IPO. A score in this range reflects mixed views — some analysts are positive while others are cautious. Read the individual analyst verdicts above for more context.

What was the actual listing price of GSP Crop Science IPO?

GSP Crop Science IPO listed on March 24, 2026 at ₹329, against the issue price of ₹320 — a gain of +2.81% (₹9 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of GSP Crop Science IPO?

GSP Crop Science IPO was priced at ₹304-320 per share. The minimum lot size is 46 shares, making the minimum investment approximately ₹14,720 at the upper end of the price band. Subscription ran from 16 Mar 2026 to 18 Mar 2026.

Explore GSP Crop Science IPO further

Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.

GSP Crop Science IPO review

A verdict is an opinion, not a guarantee.

IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.

Join the WhatsApp channel Full IPO details

Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.

Consensus
Apply
Score
67 / 100
Listed at
₹329
Full IPO details